The short answer. A DAMO franchise is a clinical business, not a salon or a beauty franchise. The master licensee is buying a documented diagnostic-and-treatment protocol, a licensed multidisciplinary team structure, and a retail home-care line — and the qualifying question is whether you can recruit and supervise clinical staff in your market, not whether you can fit out a room. VF Franchise Consulting publishes an investment level of US$500,000 for the brand; everything else, including territory and development economics, is disclosed under NDA. If you run medical, wellness or aesthetic clinics already, this is an adjacency. If you do not, it is a category change.
DAMO® Hair Loss Solution is a non-surgical clinical hair and scalp restoration brand founded in New York by Dr. June Noh, a Doctor of Traditional Chinese Medicine and Certified Clinical Trichologist with more than 16 years of clinical practice. The business runs on the proprietary DAMO Response-Based Hair Recovery System — a documented, transferable clinical protocol rather than a founder’s personal technique. Six operating locations across the United States exist precisely to prove that point: the model runs without the founder in the room.
Revenue arrives in two layers. In-clinic treatments carry the margin; a retail home-care product line carries the recurrence. Under a master licence, a third layer opens — sub-licensing rights within the territory.
The system is structured in four stages, and understanding them is how an operator judges staffing:
Stages one and four are where most wellness operators underestimate the build. Diagnosis requires equipment and trained interpretation. Sustained recovery requires a follow-up discipline closer to a medical practice than a spa.
DAMO’s clinical bench spans Traditional Chinese Medicine practitioners, Nurse Practitioners, RNs, clinical trichologists, phlebotomy technicians and nutrition specialists. A franchisee is not hiring therapists. They are assembling a licensed multidisciplinary team under one roof — which is why market selection turns on regulatory fit before it turns on consumer demand.
Across Asia Pacific and MENA, the candidates who convert on clinical wellness brands share a short list of traits. The table below is a fit assessment, not a financial one.
| Operator background | Clinical licensing capability | Retail product capability | Fit for a DAMO master licence |
|---|---|---|---|
| Existing medical or aesthetic clinic group | In place | Usually partial | Strongest — protocol layers onto existing compliance |
| Hospital or polyclinic operator | In place | Limited | Strong, if a retail arm can be built |
| Premium wellness or spa group | Must be built | In place | Viable with a clinical hiring plan committed up front |
| Pharmacy or health retail chain | Partial | In place | Viable for the product layer; clinics need a partner |
| Pure F&B or retail franchisee | Absent | Partial | Weak — the licensing burden sits outside core competence |
| Family office with clinical operating partner | Via partner | Via partner | Strong, provided the operator is named before signing |
Hair loss affects a very large and growing share of the global population, which makes the demand side unusually stable across cultures. What varies is the regulatory frame and the willingness to pay for a clinical rather than cosmetic answer. Markets with high existing awareness of U.S. and Korean-origin wellness brands convert fastest — a dynamic visible throughout Korean brand expansion across Southeast Asia and the Gulf.
Gulf markets combine high disposable income with strong appetite for premium clinical wellness, and the ownership structures are now straightforward enough that international brands enter without a local majority partner in several jurisdictions — see our review of UAE entry routes and ownership structures and how brands enter Saudi Arabia. In Southeast Asia, Vietnam’s rising urban middle class and its registration framework make it a credible first-clinic market; the mechanics are set out in our Vietnam franchising guide.
Standardised protocols, certification and operational manuals are the transferable assets. DAMO’s founder also operates the DAMO Trichology Institute & Lab, which is the training and credentialling backbone — a structural advantage over hair-loss offerings that rely on a device supplier’s manual. Brand representation across Asia Pacific and MENA sits with VF Franchise Consulting, whose directors are full-time and in-market in Vietnam, Singapore, Korea and Japan.
Prospective partners can review the brand’s own clinical positioning on the DAMO International Medical Group site.
Only with a clinical partner named before signing. The protocol is transferable; the licensing, supervision and staffing obligations are not. Candidates who already run regulated healthcare or aesthetic operations carry the least execution risk.
VF Franchise Consulting publishes an investment level of US$500,000 for the brand. Territory fees, unit fees, royalty and marketing terms are disclosed under NDA to qualified candidates, alongside the countries currently available.
Three things: it is non-surgical, it is protocol-driven rather than device-driven, and it combines Traditional Chinese Medicine with Western clinical disciplines under one roof. The founder has treated more than 2,000 cases across over 30 nationalities, which matters when a protocol has to hold across diverse hair types.
DAMO is releasing its first-ever master licence, with exclusive rights available across Asia Pacific and MENA. Availability is territory-specific and disclosed under NDA. Our earlier briefing on the DAMO master licence opportunity covers the structure in more detail.
Clinical wellness sits at the higher-commitment end of the services spectrum. For a broader view of what else is available, see non-food service franchise opportunities across Asia Pacific and MENA, the Sanondaf B2B decontamination model, and Physique 57’s studio development rights.
Most wellness brands sell a room and a routine. DAMO sells a clinical outcome, which is harder to deliver and correspondingly harder to copy. The right partner is the one who reads that as an advantage rather than an obstacle — and who has already solved clinical staffing in their market before the first site is signed. If that describes your platform, the conversation is worth having; our overview of how cross-border franchise advisory works explains what the qualification process involves.
